WeVote

Bill

Bill

HB 1062

Providing coverage for biomarker testing.

2025-2026 Regular Session Introduced by Emily Alvarado and 19 co-sponsors

HB 1062 mandates Washington health insurers cover biomarker testing to improve disease detection and personalized treatment access while potentially raising insurance costs.

Public hearing in the House Committee on Health Care & Wellness at 1:30 PM.
0

WeVote — Public opinion

No community votes yet. Be the first to weigh in from the Vote tab.

Bill text & amendments